Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Collegium Pharmaceutical (COLL) over the last 9 years, with Q3 2025 value amounting to 0.14%.

  • Collegium Pharmaceutical's Return on Capital Employed fell 800.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.19% for FY2024, which is 500.0% down from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Return on Capital Employed is 0.14%, which was down 800.0% from 0.11% recorded in Q2 2025.
  • Collegium Pharmaceutical's Return on Capital Employed's 5-year high stood at 0.33% during Q2 2024, with a 5-year trough of 0.02% in Q1 2022.
  • For the 5-year period, Collegium Pharmaceutical's Return on Capital Employed averaged around 0.13%, with its median value being 0.14% (2025).
  • In the last 5 years, Collegium Pharmaceutical's Return on Capital Employed surged by 2100bps in 2021 and then crashed by -2100bps in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Capital Employed (Quarter) stood at 0.04% in 2021, then rose by 10bps to 0.04% in 2022, then surged by 438bps to 0.24% in 2023, then crashed by -37bps to 0.15% in 2024, then dropped by -8bps to 0.14% in 2025.
  • Its Return on Capital Employed was 0.14% in Q3 2025, compared to 0.11% in Q2 2025 and 0.12% in Q1 2025.